MRF-Logo2019-Horizontal-RGB
Interview with Dr. Jim Allison ‘ The making of Yervoy (anti-CTLA-4)”
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Interview with Dr. Jim Allison ‘ The making of Yervoy (anti-CTLA-4)”

› Forums › General Melanoma Community › Interview with Dr. Jim Allison ‘ The making of Yervoy (anti-CTLA-4)”

  • Post
Viewing 5 reply threads
  • Replies
      • April 26, 2012 at 2:20 am
      kylez
      Participant

        Thanks Jimmy, that's an amazing video, to "meet" the principal researcher behind this immiune therapy. And really iinformative to hear what he's thinking about the current state of the art.

        For my part I'm at 10 months post-Gamma Knife (brain mets #2, 3, 4 and 5) and 8 months post-IPI cycle #4… the anti-CTLA4 blocker he championed through all kinds of obstacles (also per the 4/23 New Yorker mag article).

        • April 26, 2012 at 2:20 am
        kylez
        Participant

          Thanks Jimmy, that's an amazing video, to "meet" the principal researcher behind this immiune therapy. And really iinformative to hear what he's thinking about the current state of the art.

          For my part I'm at 10 months post-Gamma Knife (brain mets #2, 3, 4 and 5) and 8 months post-IPI cycle #4… the anti-CTLA4 blocker he championed through all kinds of obstacles (also per the 4/23 New Yorker mag article).

          • April 26, 2012 at 2:20 am
          kylez
          Participant

            Thanks Jimmy, that's an amazing video, to "meet" the principal researcher behind this immiune therapy. And really iinformative to hear what he's thinking about the current state of the art.

            For my part I'm at 10 months post-Gamma Knife (brain mets #2, 3, 4 and 5) and 8 months post-IPI cycle #4… the anti-CTLA4 blocker he championed through all kinds of obstacles (also per the 4/23 New Yorker mag article).

            • April 29, 2012 at 5:22 am
            momof2kids
            Participant

              I will have to watch this tomorrow when I have more time.  Pissed off I have cancer….but THANKFUL that Yervoy/IPI has worked the last 6 months for me, and hopefully will continue to do so for a lot longer!

              • April 29, 2012 at 5:22 am
              momof2kids
              Participant

                I will have to watch this tomorrow when I have more time.  Pissed off I have cancer….but THANKFUL that Yervoy/IPI has worked the last 6 months for me, and hopefully will continue to do so for a lot longer!

                • April 29, 2012 at 5:22 am
                momof2kids
                Participant

                  I will have to watch this tomorrow when I have more time.  Pissed off I have cancer….but THANKFUL that Yervoy/IPI has worked the last 6 months for me, and hopefully will continue to do so for a lot longer!

              Viewing 5 reply threads
              • You must be logged in to reply to this topic.
              About the MRF Patient Forum

              The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

              The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

              Popular Topics